Extracellular vesicles (EVs) are involved in the development and progression of neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease. Moreover, EVs have the capacity to modify the...
Read More »COVID‐19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement
Exosome extracellular vesicles as biologic therapy for COVID‐19 are discussed for two areas. The first involves the growing use of mesenchymal stromal cells (MSCs) for the profound clinical cytokine storm and severe pneumonia in COVID‐19 patients. Instead, it is recommended ...
Read More »NX Prenatal Announces Publication of First Trimester Exosome Liquid Biopsy Test Data for Preeclampsia Risk
NX Prenatal Inc today announced the publication of new data demonstrating that exosome-associated protein biomarkers derived from first trimester maternal plasma are key in predicting the overall risk of...
Read More »Cell Guidance Systems introduces Exo-spin 96 exosome purification kit
Enables rapid purification of exosomes from blood and other samples Cell Guidance Systems Ltd, a specialist in exosome research reagents and services, today announced the launch of a new product for the purification of exosomes from blood and other samples. ...
Read More »MDimune’s BioDrone platform technology based on cell-derived vesicles received “Best Cell Therapy Technology of the Year” award at Cell Therapy World Asia 2020
MDimune Inc., a biotech company developing BioDrone® platform technology based on cell-derived vesicles (CDVs), was awarded the “Best Cell Therapy Technology of the Year” at the annual Cell Therapy...
Read More »VivaZome and Cytiva partner on downstream technology for exosome purification
VivaZome Therapeutics and Cytiva, formerly part of GE Healthcare Life Sciences, have entered into an agreement where Cytiva’s range of purification...
Read More »Post-doc position available – EVs in wound healing and tissue regeneration biology
We are searching for a full-time post-doctoral fellow in the Hansjörg Wyss Department of Plastic Surgery at the New York University Langone Medical Center...
Read More »VivaZome licenses University of Adelaide stem cell technology to support development and commercialization of exosome-based therapeutics
VivaZome Therapeutics Pty Ltd and the University of Adelaide today announced that they have entered into a series of agreements encompassing licensing of...
Read More »MDimune to collaboration with Paracelsus Medical University for EV therapeutics development
MDimune Inc., a cell-derived vesicle (CDVs)-based therapeutics company with BioDrone® platform technology, announced on April 30th, 2020, the...
Read More »Exosome Extracellular Vesicles: A Vehicle for Simultaneous Immune and Genetic Therapy
Exosomes are newly recognized universal minute nanosize particles made by all cells in all species that transfer genetic instructions between cells...
Read More »